Vaccine is a biological preparation which protects an individual and its community with immunity against a specific infection. It contains substances that resembles a disease-causing microorganism often made from attenuated or inactive forms of the pathogen, its toxins or surface proteins.

Influenza or more commonly known as flu is a contagious respiratory infection caused by the influenza viruses. It is typically spread through small airborne droplets when an individual sneezes, coughs or talks.

Pasaca Capital, Inc. with its portfolio company Innova Medical Group Establish Joint Venture with Sinopharm Group to Improve Access to COVID-19 Vaccines Dr. Robert Redfield, Chief Scientific Advisor to Pasaca and Former US CDC Commissioner and Dr. Yichen Lu will lead the vaccine effort for Pasaca and Innova Sinopharm’s China

A protein-based COVID-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a stronger antibody response against the Omicron variant than a third dose of the original, a study showed.

Virus protein is the component of the new Sinopharm vaccine, says doctors

Pasaca Capital, Inc. with its portfolio company Innova Medical Group Establish Joint Venture with Sinopharm Group to Improve Access to COVID-19 Vaccines Dr. Robert Redfield, Chief Scientific Advisor to Pasaca and Former US CDC Commissioner and Dr. Yichen Lu will lead the vaccine effort for Pasaca and Innova Sinopharm’s China